Xenon Pharmaceuticals XENE
NASDAQ XENE
$36.99 -0.26 (-0.70%)
As of: Sep 30, 2026 · 1:52 PM EDT

Xenon Pharmaceuticals Inc. (XENE) Receivables - Other (2019 - 2026)

Updated

Xenon Pharmaceuticals' Receivables - Other came in at $1.63 million for Q2 2026, up 48.5% from $1.1 million a year earlier and up 39.8% from the prior quarter.

Analysis

Xenon Pharmaceuticals Inc. (XENE) Receivables - Other (2019 - 2026) Analysis & Trends

At the end of FY2025, Xenon Pharmaceuticals' Receivables - Other was $1.37 million, down 6.7% from FY2024.

  • Going back by year, Receivables - Other was $1.47 million in FY2024.
  • Business Quant data shows XENE's Receivables - Other at $1.17 million (Q1 2026), $1.37 million (Q4 2025) and $812,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.63 Mn
Mar 31, 2026 1.17 Mn
Dec 31, 2025 1.37 Mn
Sep 30, 2025 812,000.00
Jun 30, 2025 1.10 Mn
Dec 31, 2024 1.47 Mn
Dec 31, 2019 448,000.00
API Access

Xenon Pharmaceuticals Inc. Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=XENE&period=max&api_key=YOUR_API_KEY